Yıl: 2022 Cilt: 11 Sayı: 4 Sayfa Aralığı: 1511 - 1515 Metin Dili: İngilizce DOI: 10.5455/medscience.2022.08.196 İndeks Tarihi: 08-05-2023

The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients

Öz:
The present study aims to investigate the effect of the predictive value of Neutrophil to Lymphocyte Ratio (NLR) and several routine laboratory tests on mortality in patients with positive Coronavirus disease-2019 (COVID-19) tests who were treated at Istanbul Training and Research Hospital. Routine laboratory data of patients with positive COVID-19 Real Time-Polymerase Chain Reaction (RT-PCR) results were obtained via the hospital information system. The laboratory tests included ferritin, C-reactive protein (CRP), lactate dehydrogenase (LDH), aspartate transaminase, creatinine, urea, D-dimer, neutrophil, and lymphocyte count. The number of patients was 2774 and they were admitted to Istanbul Training and Research Hospital between March 10 and June 10, 2020. The statistical data were obtained using SPSS 17.0 ver- sion. The patients were divided into two groups, one for mortality (n= 74 patients) and the other for non-mortality (N=2700 patients). In both mortality and non-mortality groups, the ratio of males was higher than females and the difference was not significant (p>0.05). 87.8% of those who lost their lives were treated in the intensive care unit (p<0.05). All parameters were statistically significant between mortality and non-mortality groups (p<0.05). In patients with mortality, diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), malignity, kidney failure, immunosuppressive treatment, and COVID-19-associated computerized tomography findings were higher (p<0.05). By the univariate analysis outcomes, all research parameters were significantly associated with mortality (p<0.05). Binary logistic regression analy- sis demonstrated that NLR, CRP, and LDH had predictive values for mortality in multivariate analysis (p<0.05). It is prominent that the NLR, CRP, and LDH were discrete from all other parameters and had a high predictive value among the values at the time of admission to the hospital in the study.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Hang H, Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol. 2021;19:685–700.
  • 2. World Health Organisation, WHO. Virtual Press Conference on COVID-19 (2020). https://www.who.int/docs/default-source/coronaviruse/transcripts/ who-audio-emergencies-coronavirus-press-conference-full-and-final- 11mar2020.pdf?sfvrsn=cb432bb3_2 access date 08.2022
  • 3. Wadman M, Couzin-Frankel J, Kaiser J, Matacic C. A rampage through the body. Science. 2020;368:356-60.
  • 4. Robba C, Battaglini D, Pelosi P, Rocco PRM. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev Respir Med. 2020;14:865-68.
  • 5. Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324:782-93.
  • 6. Tomo S, Karli S, Dharmalingam K, et al. The clinical laboratory: a key player in diagnosis and management of COVID- 19. eJIFCC. 2020;31:326- 46.
  • 7. Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020;58:1063–9.
  • 8. Alamin AA, Yahia AIO. Hematological Parameters Predict Disease Severity and Progression in Patients with COVID-19: a Review Article. Clin Lab. 2021;67.
  • 9. Lippi G, Horvath AR, Adeli K. Editorial and executive summary: IFCC interim guidelines on clinical laboratory testing during the COVID-19 pandemic. Clin Chem Lab Med. 2020;58:1965–9.
  • 10. International Federation of Clinical Chemistry and Laboratory Medicine. https://www.ifcc.org/resources-downloads/ifcc-information-guide-on- covid-19-introduction/ access date 08.2022
  • 11. World Health Organization, Coronavirus disease 2019 (COVID-19) Situation Report. https://www.who.int/emergencies/diseases/novel- coronavirus-2019/situation-reports access date 08.2022
  • 12. Ejaz H, Alsrhani A, Zafar A, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13:1833–9.
  • 13. Gallo Marin B, Aghagoli G, Lavine K, et al. Predictors of COVID-19 severity: a literature review. Rev Med Virol. 2021;31:1-10.
  • 14. Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81:e6-12.
  • 15. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-ınfected pneumonia in Wuhan, China. JAMA. 2020;323:1061-9.
  • 16. Liu X, Zhang R, He G. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol. 2020;99:1421-8.
  • 17. Khartabil TA, Russcher H, van der Ven A, de Rijke YB. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients. Crit Rev Clin Lab Sci. 2020;57:416-31.
  • 18. Guo J, Fang J, Huang X, et al. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: a metaanalysis of results from multivariate analysis. Int J Surg. 2018;60:216–23.
  • 19. Simadibrata DM, Calvin J, Wijaya AD, Ibrahim NAA. Neutrophil-to- lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis. Am J Emerg Med. 2021;42:60-9.
  • 20. Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019- nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364–74.
  • 21. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846-8.
  • 22. Liu W, Tao Z-W, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J. 2020;133:1032-8.
  • 23. Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58:1021-8.
  • 24. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623.
  • 25. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol 2020;95:834-47.
  • 26. Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–70.
  • 27. Liao D, Zhou F, Luo L, et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol 2020;7:e671–e678.
  • 28. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.
  • 29. Wool GD, Miller JL. The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology. 2020;13:1–13.
  • 30. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475-81.
  • 31. Ponti G, Maccaferri M, Ruini C, et al. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57:389-99.
  • 32. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
APA Orhan B, Deniz L, Saglam Z, Eren G, Bercik Inal B (2022). The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. , 1511 - 1515. 10.5455/medscience.2022.08.196
Chicago Orhan Bagnu,Deniz Levent,Saglam Zuhal Aydan,Eren Gülhan,Bercik Inal Berrin The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. (2022): 1511 - 1515. 10.5455/medscience.2022.08.196
MLA Orhan Bagnu,Deniz Levent,Saglam Zuhal Aydan,Eren Gülhan,Bercik Inal Berrin The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. , 2022, ss.1511 - 1515. 10.5455/medscience.2022.08.196
AMA Orhan B,Deniz L,Saglam Z,Eren G,Bercik Inal B The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. . 2022; 1511 - 1515. 10.5455/medscience.2022.08.196
Vancouver Orhan B,Deniz L,Saglam Z,Eren G,Bercik Inal B The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. . 2022; 1511 - 1515. 10.5455/medscience.2022.08.196
IEEE Orhan B,Deniz L,Saglam Z,Eren G,Bercik Inal B "The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients." , ss.1511 - 1515, 2022. 10.5455/medscience.2022.08.196
ISNAD Orhan, Bagnu vd. "The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients". (2022), 1511-1515. https://doi.org/10.5455/medscience.2022.08.196
APA Orhan B, Deniz L, Saglam Z, Eren G, Bercik Inal B (2022). The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. Medicine Science, 11(4), 1511 - 1515. 10.5455/medscience.2022.08.196
Chicago Orhan Bagnu,Deniz Levent,Saglam Zuhal Aydan,Eren Gülhan,Bercik Inal Berrin The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. Medicine Science 11, no.4 (2022): 1511 - 1515. 10.5455/medscience.2022.08.196
MLA Orhan Bagnu,Deniz Levent,Saglam Zuhal Aydan,Eren Gülhan,Bercik Inal Berrin The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. Medicine Science, vol.11, no.4, 2022, ss.1511 - 1515. 10.5455/medscience.2022.08.196
AMA Orhan B,Deniz L,Saglam Z,Eren G,Bercik Inal B The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. Medicine Science. 2022; 11(4): 1511 - 1515. 10.5455/medscience.2022.08.196
Vancouver Orhan B,Deniz L,Saglam Z,Eren G,Bercik Inal B The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients. Medicine Science. 2022; 11(4): 1511 - 1515. 10.5455/medscience.2022.08.196
IEEE Orhan B,Deniz L,Saglam Z,Eren G,Bercik Inal B "The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients." Medicine Science, 11, ss.1511 - 1515, 2022. 10.5455/medscience.2022.08.196
ISNAD Orhan, Bagnu vd. "The effect of diagnostic value of biochemical parameters on mortality in COVID-19 patients". Medicine Science 11/4 (2022), 1511-1515. https://doi.org/10.5455/medscience.2022.08.196